| 0.8 |
4.2 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 |
1.6 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 0.5 |
1.6 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.5 |
1.5 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 |
1.2 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.4 |
0.8 |
GO:0051795 |
positive regulation of catagen(GO:0051795) |
| 0.3 |
1.0 |
GO:0021793 |
chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.3 |
1.0 |
GO:1905246 |
regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.3 |
1.0 |
GO:0061075 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.3 |
1.2 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.3 |
1.2 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.3 |
0.9 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.3 |
0.9 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.3 |
0.8 |
GO:0072011 |
glomerular endothelium development(GO:0072011) |
| 0.3 |
1.3 |
GO:0090031 |
positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.3 |
3.9 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.3 |
5.0 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.3 |
0.8 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.2 |
1.0 |
GO:0072299 |
visceral serous pericardium development(GO:0061032) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.2 |
0.7 |
GO:0086097 |
phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.2 |
0.7 |
GO:0035625 |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.2 |
1.1 |
GO:1902228 |
mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.2 |
0.7 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.2 |
0.9 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.2 |
0.2 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.2 |
1.1 |
GO:0099552 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.2 |
0.7 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.2 |
0.9 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.2 |
0.8 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
1.7 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.2 |
3.7 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.2 |
0.6 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.2 |
1.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.2 |
0.6 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.2 |
1.0 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.2 |
0.6 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.2 |
2.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 |
0.7 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.2 |
0.2 |
GO:2001076 |
thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.2 |
0.5 |
GO:0021718 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.2 |
1.0 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
0.7 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.2 |
0.7 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.2 |
0.5 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.2 |
0.5 |
GO:1903410 |
lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.2 |
1.1 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 |
0.3 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.2 |
0.5 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.2 |
1.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.2 |
0.8 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.2 |
0.5 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.2 |
0.8 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 |
0.1 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.1 |
1.3 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.1 |
0.4 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.1 |
0.1 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 |
0.6 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 |
3.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.1 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
0.4 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.4 |
GO:1903056 |
regulation of melanosome organization(GO:1903056) |
| 0.1 |
0.1 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.1 |
1.0 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.1 |
0.3 |
GO:0032732 |
positive regulation of interleukin-1 production(GO:0032732) |
| 0.1 |
0.8 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 |
0.4 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.1 |
0.1 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.1 |
0.5 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.1 |
0.3 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 |
0.1 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.3 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.1 |
0.4 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.1 |
1.3 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
1.1 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.8 |
GO:0072236 |
metanephric loop of Henle development(GO:0072236) |
| 0.1 |
0.8 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
1.0 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.1 |
0.4 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.1 |
0.4 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 |
1.0 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.1 |
0.3 |
GO:0060490 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.1 |
0.8 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
0.4 |
GO:0007037 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.1 |
0.5 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.1 |
0.3 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.1 |
0.4 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.1 |
0.6 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.1 |
0.1 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.1 |
0.1 |
GO:1902256 |
apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.1 |
0.6 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.3 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.1 |
0.1 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.1 |
0.8 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.1 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
2.0 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.3 |
GO:0050820 |
positive regulation of coagulation(GO:0050820) |
| 0.1 |
0.5 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.1 |
0.7 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.1 |
0.1 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.1 |
0.8 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.1 |
0.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
1.2 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 |
0.3 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 |
0.3 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 |
0.4 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
0.3 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.1 |
1.1 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.1 |
0.3 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 |
0.2 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 |
1.1 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
1.4 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.1 |
0.3 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.1 |
0.2 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.1 |
0.4 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.1 |
0.1 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 |
1.4 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.1 |
0.3 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 |
0.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.1 |
0.6 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.3 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
0.5 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.2 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.1 |
1.0 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 |
0.3 |
GO:0035750 |
protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.1 |
0.9 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
0.3 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.1 |
0.3 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.3 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.1 |
0.3 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.1 |
0.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.5 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.1 |
2.1 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.3 |
GO:1903515 |
regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.1 |
0.1 |
GO:0072003 |
kidney rudiment formation(GO:0072003) |
| 0.1 |
0.5 |
GO:0060978 |
angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.1 |
0.3 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 |
0.5 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 0.1 |
0.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
1.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.3 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.1 |
0.5 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.1 |
0.4 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
0.2 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.1 |
1.2 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.1 |
0.4 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
0.9 |
GO:0032222 |
regulation of synaptic transmission, cholinergic(GO:0032222) |
| 0.1 |
0.2 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.1 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.1 |
0.4 |
GO:0002503 |
peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.1 |
0.3 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.1 |
0.3 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
0.3 |
GO:1903400 |
L-arginine transmembrane transport(GO:1903400) mitochondrial L-ornithine transmembrane transport(GO:1990575) |
| 0.1 |
0.3 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.1 |
0.3 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.1 |
0.3 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 |
0.3 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.3 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 |
0.4 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.1 |
0.6 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.4 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) oncogene-induced cell senescence(GO:0090402) |
| 0.1 |
0.8 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.2 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 0.1 |
0.3 |
GO:0036483 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.1 |
0.5 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.1 |
0.2 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.1 |
0.1 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
1.1 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.7 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.1 |
0.4 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.1 |
0.8 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.1 |
0.1 |
GO:0001767 |
establishment of lymphocyte polarity(GO:0001767) |
| 0.1 |
0.6 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.6 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.1 |
0.2 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
| 0.1 |
0.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.3 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 0.1 |
0.1 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.1 |
0.2 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 |
0.8 |
GO:0060486 |
Clara cell differentiation(GO:0060486) |
| 0.1 |
0.2 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.1 |
1.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.2 |
GO:1900111 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.1 |
0.2 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.1 |
0.2 |
GO:0015819 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
| 0.1 |
0.5 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.2 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.1 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.1 |
0.9 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
0.3 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 |
0.3 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.3 |
GO:0046671 |
negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.1 |
0.3 |
GO:0071692 |
sequestering of BMP in extracellular matrix(GO:0035582) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.1 |
0.5 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.2 |
GO:0034443 |
regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 |
0.6 |
GO:0051549 |
positive regulation of keratinocyte migration(GO:0051549) |
| 0.1 |
0.2 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.1 |
0.6 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 |
0.7 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.1 |
0.4 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.1 |
0.3 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
0.8 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.2 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.1 |
0.2 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 |
0.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.2 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.1 |
0.2 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.1 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.1 |
0.4 |
GO:0061031 |
endodermal digestive tract morphogenesis(GO:0061031) |
| 0.1 |
2.8 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.3 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.1 |
0.3 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
0.4 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 |
0.1 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 |
0.3 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.1 |
0.2 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.1 |
0.1 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.3 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.1 |
0.9 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.3 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.1 |
0.3 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.1 |
0.3 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 |
0.3 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
0.3 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 |
0.3 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.1 |
0.1 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.1 |
0.2 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.1 |
0.3 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 |
0.1 |
GO:0035802 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.1 |
0.2 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 |
0.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.3 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.1 |
0.6 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.1 |
0.5 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.1 |
GO:0060577 |
pulmonary vein morphogenesis(GO:0060577) |
| 0.1 |
0.2 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 |
0.2 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
1.1 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.1 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
2.9 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
0.4 |
GO:2001028 |
positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.1 |
0.6 |
GO:0014065 |
phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.1 |
0.6 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.1 |
0.1 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.1 |
0.6 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
0.2 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.1 |
0.1 |
GO:2000410 |
regulation of thymocyte migration(GO:2000410) |
| 0.1 |
0.6 |
GO:0060717 |
chorion development(GO:0060717) |
| 0.1 |
0.2 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.1 |
GO:0072044 |
collecting duct development(GO:0072044) |
| 0.1 |
0.2 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.1 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
0.1 |
GO:1990869 |
response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.1 |
0.1 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.1 |
1.0 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.7 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.1 |
0.4 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
0.1 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.5 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
1.0 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.1 |
0.2 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
0.2 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.1 |
0.2 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 |
0.2 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
1.0 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
1.0 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.1 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 |
0.5 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 |
0.3 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
0.4 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.3 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.1 |
0.1 |
GO:1990709 |
presynaptic active zone organization(GO:1990709) |
| 0.1 |
0.2 |
GO:1903762 |
positive regulation of actin filament-based movement(GO:1903116) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.1 |
0.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.1 |
0.1 |
GO:0006563 |
L-serine metabolic process(GO:0006563) |
| 0.1 |
0.4 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.1 |
0.1 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.1 |
0.2 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.1 |
0.1 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
0.2 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 |
0.3 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 |
0.1 |
GO:0000082 |
G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.1 |
0.6 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.1 |
0.1 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.1 |
1.0 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
0.2 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.1 |
0.2 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.1 |
0.3 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.1 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.1 |
0.3 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.1 |
0.2 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 0.1 |
0.2 |
GO:0018894 |
dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.1 |
0.7 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.1 |
0.1 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.1 |
0.6 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.1 |
0.2 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.1 |
0.1 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 |
0.1 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.1 |
0.1 |
GO:0021644 |
vagus nerve morphogenesis(GO:0021644) |
| 0.1 |
0.4 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.4 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.2 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 |
0.2 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.1 |
0.1 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 |
0.4 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.1 |
0.2 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.1 |
0.1 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 |
0.8 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
0.3 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.1 |
1.7 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.1 |
0.5 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
1.0 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.2 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.1 |
0.1 |
GO:0072301 |
regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) |
| 0.1 |
0.2 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.1 |
0.2 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 |
0.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
0.1 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.1 |
0.4 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.1 |
0.3 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.1 |
0.7 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.5 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.8 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.1 |
0.2 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.1 |
0.1 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.8 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
0.2 |
GO:0061535 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) glutamate secretion, neurotransmission(GO:0061535) |
| 0.1 |
0.2 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.1 |
0.1 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
0.3 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
1.2 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.4 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
2.0 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.1 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.1 |
0.1 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.1 |
0.1 |
GO:0072112 |
renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
| 0.1 |
0.8 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
0.3 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.1 |
GO:2000018 |
regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) |
| 0.1 |
1.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.6 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 |
0.2 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 |
0.5 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.4 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.5 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.1 |
0.1 |
GO:2001038 |
regulation of cellular response to drug(GO:2001038) |
| 0.1 |
0.1 |
GO:0089718 |
amino acid import across plasma membrane(GO:0089718) |
| 0.1 |
0.3 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.2 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.2 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.0 |
0.1 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.0 |
0.1 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.0 |
0.1 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.0 |
1.1 |
GO:0043090 |
amino acid import(GO:0043090) |
| 0.0 |
0.5 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.0 |
0.1 |
GO:0030473 |
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
| 0.0 |
0.5 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.0 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.0 |
0.0 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.5 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 |
0.7 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.0 |
GO:1903363 |
negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.0 |
0.9 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.2 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.0 |
1.0 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.1 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.0 |
0.1 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.0 |
0.6 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.1 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.0 |
0.0 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.2 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.0 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.0 |
0.3 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.0 |
0.2 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
0.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.2 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.0 |
0.1 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 |
0.4 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.6 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.0 |
0.3 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.0 |
0.5 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.0 |
0.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.0 |
0.1 |
GO:0033319 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.0 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.2 |
GO:0035377 |
transepithelial water transport(GO:0035377) |
| 0.0 |
0.8 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
2.9 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.2 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 |
0.3 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.0 |
0.3 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.1 |
GO:2001113 |
negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 0.0 |
0.6 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.0 |
0.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.1 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.0 |
0.2 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.0 |
0.7 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.4 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.0 |
0.0 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.0 |
0.5 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.0 |
0.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.1 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.0 |
0.4 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.0 |
0.8 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 |
0.3 |
GO:0031063 |
regulation of histone deacetylation(GO:0031063) |
| 0.0 |
0.1 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.0 |
0.7 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.0 |
0.3 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.0 |
0.0 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.0 |
0.1 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
1.5 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.0 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 |
0.2 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.0 |
0.1 |
GO:0045081 |
negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.0 |
0.6 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.4 |
GO:1902915 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.0 |
0.3 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.0 |
0.2 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.1 |
GO:0001806 |
type IV hypersensitivity(GO:0001806) |
| 0.0 |
0.1 |
GO:0036482 |
neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.0 |
0.3 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 |
0.1 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.0 |
0.6 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
0.1 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 |
0.3 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.1 |
GO:0021551 |
central nervous system morphogenesis(GO:0021551) cardiac muscle tissue regeneration(GO:0061026) |
| 0.0 |
1.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
1.7 |
GO:0045124 |
regulation of bone resorption(GO:0045124) |
| 0.0 |
0.2 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.0 |
0.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.2 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 |
0.3 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 |
0.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.0 |
0.3 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.0 |
0.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.0 |
0.2 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.0 |
0.6 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 |
0.3 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.0 |
0.2 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.0 |
0.2 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.0 |
0.7 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.0 |
0.0 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.0 |
0.4 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.0 |
0.2 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.0 |
0.2 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.0 |
0.2 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.0 |
0.1 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.0 |
0.3 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.3 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.4 |
GO:0042053 |
regulation of dopamine metabolic process(GO:0042053) regulation of catecholamine metabolic process(GO:0042069) |
| 0.0 |
0.1 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.0 |
0.3 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.0 |
0.2 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) |
| 0.0 |
0.2 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.0 |
0.1 |
GO:0035933 |
glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
| 0.0 |
0.1 |
GO:0039007 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
| 0.0 |
1.3 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.5 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.0 |
0.1 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.0 |
1.2 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.0 |
0.2 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.1 |
GO:0000075 |
cell cycle checkpoint(GO:0000075) |
| 0.0 |
0.0 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.1 |
GO:0043385 |
mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.0 |
0.2 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 |
0.1 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
0.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.1 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.0 |
0.7 |
GO:0015684 |
ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.0 |
0.1 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.0 |
0.2 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.0 |
0.2 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.0 |
0.0 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 |
0.2 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.0 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.1 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.0 |
0.2 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.0 |
0.9 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.1 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.0 |
0.1 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.0 |
0.2 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.2 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.0 |
0.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.1 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.0 |
0.1 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.0 |
0.5 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.5 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.2 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
0.6 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.0 |
0.4 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.5 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.0 |
0.4 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.1 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.0 |
0.1 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.0 |
0.3 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.0 |
0.1 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.0 |
0.4 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.2 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.0 |
0.2 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 |
0.1 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.4 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.0 |
GO:2000561 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.0 |
0.1 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 |
0.0 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.0 |
0.4 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.0 |
0.1 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.2 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.0 |
0.4 |
GO:1901725 |
regulation of histone deacetylase activity(GO:1901725) |
| 0.0 |
0.1 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.2 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.0 |
0.7 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
0.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.0 |
0.0 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.0 |
0.1 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
1.0 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
0.2 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.0 |
0.2 |
GO:0021781 |
glial cell fate commitment(GO:0021781) |
| 0.0 |
0.2 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.0 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.0 |
0.0 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.0 |
0.2 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.0 |
0.1 |
GO:1900044 |
regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.0 |
0.1 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.0 |
0.0 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.0 |
0.1 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.0 |
0.7 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.0 |
0.1 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.0 |
0.6 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.5 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.0 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.0 |
0.2 |
GO:0045995 |
regulation of embryonic development(GO:0045995) |
| 0.0 |
0.5 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.1 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.0 |
0.1 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 |
0.0 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.0 |
0.1 |
GO:2000105 |
positive regulation of DNA-dependent DNA replication(GO:2000105) |
| 0.0 |
0.4 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.1 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.5 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.0 |
0.2 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.0 |
0.4 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.0 |
0.3 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.0 |
0.1 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 |
0.1 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.0 |
0.6 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 |
0.6 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 |
0.1 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.1 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.0 |
0.2 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.0 |
0.1 |
GO:0030218 |
erythrocyte differentiation(GO:0030218) |
| 0.0 |
0.2 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 |
0.0 |
GO:0035261 |
external genitalia morphogenesis(GO:0035261) |
| 0.0 |
0.2 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.3 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 |
0.2 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.1 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.0 |
0.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 |
0.2 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.0 |
0.0 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.0 |
0.2 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.6 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.1 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.0 |
0.7 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.0 |
0.3 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 |
0.2 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.0 |
0.6 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.0 |
0.1 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 |
0.2 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.1 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.0 |
0.0 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.0 |
0.3 |
GO:0009448 |
gamma-aminobutyric acid metabolic process(GO:0009448) |
| 0.0 |
0.1 |
GO:0050680 |
negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.0 |
0.2 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.1 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.0 |
0.4 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.5 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.5 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 |
0.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
0.2 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
| 0.0 |
0.0 |
GO:0002514 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.0 |
0.1 |
GO:0071673 |
positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.0 |
0.1 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.0 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.2 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 |
0.0 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.0 |
0.1 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.0 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.1 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 |
0.1 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.0 |
0.0 |
GO:1900076 |
regulation of cellular response to insulin stimulus(GO:1900076) |
| 0.0 |
0.0 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.0 |
0.2 |
GO:0010748 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.0 |
0.1 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.0 |
1.0 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 |
0.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.0 |
0.4 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 |
0.1 |
GO:2001180 |
negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.0 |
1.4 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.0 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.3 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.1 |
GO:0003205 |
cardiac chamber development(GO:0003205) |
| 0.0 |
0.1 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.5 |
GO:0003374 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.0 |
0.3 |
GO:0090292 |
nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.1 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.0 |
0.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
0.1 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.0 |
0.0 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
0.4 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.1 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.9 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.1 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.0 |
0.1 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.0 |
0.3 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 |
0.1 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.0 |
0.1 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.1 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
0.6 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.0 |
0.1 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.0 |
0.1 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.0 |
0.1 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 |
0.1 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.0 |
0.1 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.0 |
0.1 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.0 |
0.1 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.0 |
0.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.1 |
GO:0060479 |
lung cell differentiation(GO:0060479) |
| 0.0 |
0.1 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.0 |
0.1 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.0 |
0.1 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.0 |
0.1 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.0 |
0.3 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.0 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.0 |
0.0 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.0 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.1 |
GO:0030320 |
cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.0 |
0.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.7 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.0 |
0.1 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.0 |
0.0 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.0 |
0.0 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.5 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.1 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.0 |
0.1 |
GO:1902003 |
regulation of beta-amyloid formation(GO:1902003) |
| 0.0 |
0.3 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 |
0.1 |
GO:0050688 |
regulation of defense response to virus(GO:0050688) |
| 0.0 |
0.1 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.0 |
0.1 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.0 |
0.3 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.3 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.2 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.3 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 |
0.2 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.2 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.0 |
1.4 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.1 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.0 |
0.0 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.0 |
0.3 |
GO:0007044 |
cell-substrate junction assembly(GO:0007044) |
| 0.0 |
0.0 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.1 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.0 |
0.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.0 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.0 |
0.3 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
0.0 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.3 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.0 |
0.1 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.0 |
0.2 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.1 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 |
0.3 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
0.0 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:1902074 |
response to salt(GO:1902074) |
| 0.0 |
0.1 |
GO:0043491 |
protein kinase B signaling(GO:0043491) |
| 0.0 |
0.1 |
GO:1902510 |
regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.0 |
0.0 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.0 |
0.4 |
GO:0035729 |
cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 |
0.1 |
GO:1905045 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.0 |
0.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.0 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.0 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
1.3 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.0 |
0.0 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.0 |
0.1 |
GO:0071030 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.0 |
0.1 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.0 |
0.1 |
GO:0061309 |
cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
| 0.0 |
0.1 |
GO:0001999 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.0 |
0.0 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.0 |
0.6 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.0 |
0.1 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.0 |
0.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
1.0 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.6 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.0 |
0.4 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 |
0.0 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.0 |
0.3 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.4 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.0 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.0 |
0.1 |
GO:0048566 |
embryonic digestive tract development(GO:0048566) |
| 0.0 |
0.3 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.7 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.0 |
0.1 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.0 |
0.1 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.0 |
0.6 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.0 |
0.2 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.1 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.8 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.0 |
0.1 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 |
0.3 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 |
0.0 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.2 |
GO:0045986 |
negative regulation of smooth muscle contraction(GO:0045986) |
| 0.0 |
0.1 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.0 |
0.2 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.0 |
0.3 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.0 |
0.1 |
GO:0071378 |
cellular response to growth hormone stimulus(GO:0071378) |
| 0.0 |
0.3 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.0 |
0.0 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.0 |
0.1 |
GO:0019427 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.0 |
0.0 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.0 |
0.0 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.0 |
0.1 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.0 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.0 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 |
0.0 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.1 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.0 |
0.1 |
GO:0055015 |
ventricular cardiac muscle cell development(GO:0055015) |
| 0.0 |
0.0 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.0 |
0.0 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.0 |
0.0 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.0 |
0.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.0 |
0.0 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.0 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.1 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.0 |
0.1 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 |
0.0 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.1 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.0 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
3.0 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.1 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.0 |
0.1 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.2 |
GO:1990034 |
calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.0 |
0.2 |
GO:0043691 |
reverse cholesterol transport(GO:0043691) |
| 0.0 |
0.0 |
GO:1902285 |
semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.0 |
0.1 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.0 |
0.1 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.0 |
0.0 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.0 |
0.1 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.0 |
0.1 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.0 |
0.1 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.1 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.0 |
0.0 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.0 |
0.1 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.1 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.0 |
0.1 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.0 |
GO:0072178 |
nephric duct morphogenesis(GO:0072178) |
| 0.0 |
0.0 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.1 |
GO:0018283 |
metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.0 |
0.2 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 |
0.0 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.0 |
0.1 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 |
0.1 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.4 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.1 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.0 |
0.2 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.0 |
0.0 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.7 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.0 |
0.1 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 |
0.3 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.0 |
0.4 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.1 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.0 |
0.1 |
GO:1901908 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.0 |
0.2 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.1 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
0.1 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.0 |
0.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.0 |
GO:2000506 |
negative regulation of energy homeostasis(GO:2000506) |
| 0.0 |
0.4 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 |
0.1 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.0 |
0.1 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.1 |
GO:0098706 |
copper ion import(GO:0015677) ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.0 |
0.2 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.0 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
| 0.0 |
0.2 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.1 |
GO:0045661 |
regulation of myoblast differentiation(GO:0045661) |
| 0.0 |
0.7 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.1 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.0 |
0.1 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.1 |
GO:0044854 |
plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 0.0 |
0.0 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 |
0.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.0 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.0 |
0.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.0 |
0.0 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.0 |
0.1 |
GO:0060600 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.0 |
0.4 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 |
0.0 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.5 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 |
0.0 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.0 |
0.2 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.0 |
0.0 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.0 |
0.0 |
GO:0019448 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.0 |
0.4 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.0 |
0.1 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 |
0.0 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 |
0.1 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 |
0.1 |
GO:0060397 |
creatinine metabolic process(GO:0046449) JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 |
0.0 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 |
0.0 |
GO:0021696 |
cerebellar cortex morphogenesis(GO:0021696) |
| 0.0 |
0.1 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.0 |
0.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.3 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.0 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.0 |
0.0 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.1 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
| 0.0 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.1 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.0 |
0.2 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.0 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.0 |
0.0 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.0 |
0.4 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.1 |
GO:2000452 |
CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.0 |
0.5 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.0 |
0.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.3 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.0 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
0.1 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.0 |
0.0 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.0 |
0.9 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.1 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.2 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.2 |
GO:0016236 |
macroautophagy(GO:0016236) |
| 0.0 |
0.2 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.0 |
0.3 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 |
0.1 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 |
0.1 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.0 |
0.1 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 |
0.4 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.1 |
GO:0043622 |
cortical microtubule organization(GO:0043622) |
| 0.0 |
0.0 |
GO:0019883 |
antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.0 |
0.0 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 0.0 |
0.1 |
GO:2000058 |
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
| 0.0 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.0 |
0.1 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 |
0.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.5 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.0 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.0 |
0.0 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 |
0.0 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.0 |
0.4 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.0 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 |
0.1 |
GO:0033483 |
gas homeostasis(GO:0033483) |
| 0.0 |
0.0 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.0 |
0.0 |
GO:1901984 |
negative regulation of protein acetylation(GO:1901984) |
| 0.0 |
0.1 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.0 |
0.0 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.0 |
GO:0009798 |
axis specification(GO:0009798) |
| 0.0 |
0.1 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.0 |
0.0 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.0 |
0.0 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.0 |
0.0 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.0 |
0.1 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.0 |
0.0 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.0 |
0.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.1 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 |
0.0 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.0 |
0.1 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.0 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.2 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
0.0 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.0 |
0.1 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.0 |
0.0 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.0 |
1.4 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.1 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
0.0 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.0 |
0.0 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.0 |
0.1 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.0 |
0.2 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.0 |
0.2 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.0 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
| 0.0 |
0.1 |
GO:0051253 |
negative regulation of RNA metabolic process(GO:0051253) |
| 0.0 |
0.3 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 |
0.3 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.0 |
0.0 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.0 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.0 |
0.1 |
GO:0060315 |
negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.0 |
0.0 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.0 |
0.0 |
GO:0033084 |
regulation of immature T cell proliferation in thymus(GO:0033084) |
| 0.0 |
0.7 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.0 |
0.2 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
0.1 |
GO:0070328 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 |
0.2 |
GO:0018216 |
peptidyl-arginine methylation(GO:0018216) |
| 0.0 |
0.0 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.0 |
0.0 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.0 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.0 |
0.0 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.0 |
0.2 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.0 |
0.0 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.0 |
0.0 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.2 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 |
0.0 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.0 |
0.1 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.0 |
0.0 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.0 |
0.1 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 |
0.1 |
GO:0043266 |
regulation of potassium ion transport(GO:0043266) |
| 0.0 |
0.1 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 0.0 |
0.0 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 |
0.1 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.0 |
0.0 |
GO:1904378 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
0.6 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.0 |
0.0 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.0 |
0.0 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 |
0.1 |
GO:0008216 |
spermidine metabolic process(GO:0008216) |
| 0.0 |
0.1 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 |
0.0 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.2 |
GO:0002860 |
natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.0 |
0.1 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 0.0 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.0 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.0 |
0.2 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.0 |
0.0 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.0 |
0.0 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 |
0.0 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.0 |
0.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.1 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.0 |
0.0 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.0 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.0 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 |
0.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.0 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.0 |
0.0 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.0 |
0.1 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.0 |
0.0 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.1 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 |
0.0 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.0 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.0 |
0.1 |
GO:1900116 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 |
0.1 |
GO:1903432 |
regulation of TORC1 signaling(GO:1903432) |
| 0.0 |
0.2 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.0 |
0.1 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.0 |
0.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.5 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.0 |
GO:0033028 |
myeloid cell apoptotic process(GO:0033028) |
| 0.0 |
0.1 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.0 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.0 |
0.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.0 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.2 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.1 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 |
0.2 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.1 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.4 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.1 |
GO:0071276 |
cellular response to cadmium ion(GO:0071276) |
| 0.0 |
0.2 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.0 |
0.4 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 |
0.3 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.0 |
0.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.1 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.2 |
GO:0070849 |
response to epidermal growth factor(GO:0070849) |
| 0.0 |
0.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.1 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.0 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.0 |
0.0 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 |
0.0 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
0.0 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.0 |
0.1 |
GO:0031179 |
peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.0 |
0.1 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.0 |
5.5 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.0 |
1.0 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.0 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.0 |
GO:2000674 |
regulation of type B pancreatic cell apoptotic process(GO:2000674) |
| 0.0 |
0.0 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.0 |
0.1 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.0 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.0 |
0.8 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.6 |
GO:0071431 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 |
0.0 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 |
0.2 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.0 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.1 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 |
0.1 |
GO:0010833 |
telomere maintenance via telomere lengthening(GO:0010833) |
| 0.0 |
0.0 |
GO:0051610 |
serotonin uptake(GO:0051610) |
| 0.0 |
0.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.1 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.1 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.0 |
0.0 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
1.1 |
GO:2000117 |
negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 |
0.2 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.0 |
0.0 |
GO:0010518 |
positive regulation of phospholipase activity(GO:0010518) |
| 0.0 |
0.0 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.0 |
0.1 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.0 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.0 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.2 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.0 |
0.1 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.0 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.0 |
0.0 |
GO:0043311 |
positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.0 |
0.0 |
GO:1901142 |
insulin metabolic process(GO:1901142) |
| 0.0 |
0.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 |
0.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.0 |
GO:0052199 |
negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.0 |
0.1 |
GO:2000758 |
positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.0 |
0.3 |
GO:0002385 |
mucosal immune response(GO:0002385) |
| 0.0 |
0.1 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.0 |
0.1 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.0 |
0.0 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.0 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) regulation of glutamate metabolic process(GO:2000211) |
| 0.0 |
0.2 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
